Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steve Singh, MD
Washington DC VA Medical Center, Washington, DC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington Dc Va Medical Center, Washington, Dc
Washington D.C., District of Columbia, United States
- North Florida/south Georgia Veterans Health System, Gainesville, Fl
Gainesville, Florida, United States
- Minneapolis Va Health Care System, Minneapolis, Mn
Minneapolis, Minnesota, United States
- Va Portland Health Care System, Portland, Or
Portland, Oregon, United States
- Tennessee Valley Healthcare System Nashville Campus, Nashville, Tn
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Aug 2015
- Primary completion
- 6 Nov 2020
- Completion
- 6 Nov 2020
- Last update posted
- 31 Jul 2024
- Registered enrollment
- 167
- Registry id
- NCT02121158
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.